Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in hospitalized adults with COVID-19
IRCT20220612055149N1Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Fenofibrate + standard of care with Placebo + standard of care (2 arms). Primary endpoints: Mortality and Need for intensive care unit admission. Started May 2021; status: completed.
02
Drugs
fenofibrate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20220612055149N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220612055149N1.